InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

- Current share price for IMR : $1.585

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$568 Update on Clinical Sites and Appointment of COO 30 Dec 2020 9:13AM $2.290 $1.585 fallen by 30.79%
$568 Appendix 2A - Exercise of Options 24 Dec 2020 9:06AM $2.300 $1.585 fallen by 31.09%
$568 Change in Substantial Holding 18 Dec 2020 11:04AM $2.250 $1.585 fallen by 29.56%
$568 Imricor Signs Supply and Sales Agreement with Osypka 11 Dec 2020 10:18AM $2.300 $1.585 fallen by 31.09%
$568 Appendix 2A - SPP 4 Dec 2020 10:20AM $2.550 $1.585 fallen by 37.84%
$568 Imricor Completes SPP 2 Dec 2020 9:57AM $2.450 $1.585 fallen by 35.31%
$568 Imricor to Present at Bell Potter Healthcare Conference 26 Nov 2020 8:21AM $2.510 $1.585 fallen by 36.85%
$568 Imricor Signs New Purchase Agreement and Market Update 25 Nov 2020 9:08AM $2.430 $1.585 fallen by 34.77%
$568 Upcoming Release from Escrow Notification 18 Nov 2020 9:39AM $2.520 $1.585 fallen by 37.10%
$568 Appendix 2A 18 Nov 2020 9:36AM $2.520 $1.585 fallen by 37.10%
$568 Appendix 3G 18 Nov 2020 9:33AM $2.520 $1.585 fallen by 37.10%
$568 Security Purchase Plan Booklet Sent to Eligible Holders 6 Nov 2020 11:59AM $2.580 $1.585 fallen by 38.57%
$568 Cleansing Notice 5 Nov 2020 9:25AM $2.640 $1.585 fallen by 39.96%
$568 Appendix 2A 4 Nov 2020 8:50AM $2.680 $1.585 fallen by 40.86%
$568 Proposed issue of Securities - IMR 30 Oct 2020 10:11AM $2.550 $1.585 fallen by 37.84%
$568 Appendix 4C - Quarterly Report and Business Update 30 Oct 2020 10:09AM $2.550 $1.585 fallen by 37.84%
$568 Successful Completion of Placement and Launch of SPP 30 Oct 2020 10:07AM $2.550 $1.585 fallen by 37.84%
$568 Trading Halt 29 Oct 2020 9:51AM $2.550 $1.585 fallen by 37.84%
$568 Imricor Signs Purchase Agreement with UKSH in Germany 28 Oct 2020 8:30AM $2.440 $1.585 fallen by 35.04%
$568 Imricor Signs Purchase Agreement with ICPS in France 27 Oct 2020 8:34AM $2.380 $1.585 fallen by 33.40%
$568 Leipzig Heart Centre Received Ethics Committee Approval 12 Oct 2020 9:45AM $2.720 $1.585 fallen by 41.73%
$568 Ceasing to be a substantial holder 6 Oct 2020 4:29PM $2.740 $1.585 fallen by 42.15%
$568 Change in substantial holding 5 Oct 2020 4:59PM $2.680 $1.585 fallen by 40.86%
$568 Imricor Signs Purchase Agreement with MUMC 30 Sep 2020 9:11AM $2.590 $1.585 fallen by 38.80%
$568 Imricor Signs Purchase Agreement with Bad Neustadt Campus 29 Sep 2020 9:18AM $2.470 $1.585 fallen by 35.83%

476 - 500 of 602 results

Page 20 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.